The tablet Barri contains Baricitinib and is made by Beximco Pharmaceuticals Ltd. The medicine is taken by mouth.
There are 14 brands of Baricitinib listed in Bangladesh. 11 of them have a lower unit price than Barri. The lowest listed price is Baricit 2 mg Tablet at ৳ 20.00 per unit.
What is Barri 4 mg Tablet?
Barri 4 mg tablet is a medicine made by Beximco Pharmaceuticals Ltd. Barri 4 mg tablet contains Barriinib, a Janus kinase (JAK) inhibitor. Barriinib may be used alone or with methotrexate or other disease-modifying antirheumatic drugs. Whether it suits you is a decision for your doctor.
Uses of Barri
The medicine is taken by mouth. Barri 4 mg tablet is used to treat moderately to severely active rheumatoid arthritis in adults who have had an inadequate response to one or more TNF antagonist therapies. It may be prescribed alone or in combination with methotrexate or other disease-modifying antirheumatic drugs. Ask your doctor whether it is right for your condition.
How to use Barri
Regular follow-up and blood tests may be arranged by your doctor to check your response and monitor for unwanted effects. Swallow the tablet with water. Barri is taken by mouth. Follow your doctor's instructions carefully. The doctor decides the dose and how long you take it, including any change if you also take certain other medicines. Complete the course exactly as prescribed.
Side effects of Barri
The doctor or pharmacist can explain what to watch for. Like all medicines, Barri 4 mg tablet can cause side effects. Your doctor may check your blood regularly. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
It should not be started if you have an active serious infection, including active tuberculosis, or certain low blood counts. It is not known whether Barriinib harms an unborn baby, and women are advised not to breastfeed while taking it. Barri 4 mg tablet is not suitable for everyone. Your doctor will decide if this medicine is appropriate for you.
Frequently asked questions
What is Barri used for?
The medicine is taken by mouth. Barri 4 mg tablet is used to treat moderately to severely active rheumatoid arthritis in adults who have had an inadequate response to one or more TNF antagonist therapies.
How do I use Barri correctly?
Regular follow-up and blood tests may be arranged by your doctor to check your response and monitor for unwanted effects. Swallow the tablet with water.
What should I watch for while using Barri?
The doctor or pharmacist can explain what to watch for. Like all medicines, Barri 4 mg tablet can cause side effects.
Baricitinib is a Janus kinase (JAK) inhibitor indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.
Limitation of Use: Use of Baricitinib in combination with other ... Read moreBaricitinib is a Janus kinase (JAK) inhibitor indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.
Limitation of Use: Use of Baricitinib in combination with other JAK inhibitors, biologic DMARDs or with potent immunosuppressants such as Azathioprine and cyclosporine is not recommended.
Pharmacology
Baricitinib is a Janus kinase (JAK) inhibitor. JAKs are intracellular enzymes which transmit signals arising from cytokine or growth factor-receptor interactions on the cellular membrane to influence cellular processes of hematopoiesis and immune cell function. Within the signaling pathway, JAKs phosphorylate and activate Signal Transducers and Activators of Transcription (STATs) which modulate intracellular activity including gene expression. Baricitinib modulates the signaling pathway at the point of JAKs, preventing the phosphorylation and activation of STATs.
Dosage & Administration
The recommended dose of Baricitinib is 2 mg once daily. Baricitinib may be used as monotherapy or in combination with Methotrexate or other DMARDs.
Interaction
The recommended dose of Baricitinib in patients taking strong Organic Anion Transporter 3 (OAT3) inhibitors (e.g., probenecid) is 1 mg once daily
Contraindications
Anemia: Avoid initiation or interrupt Baricitinib in patients with hemoglobin less than 8 g/dL.
Lymphopenia: Avoid initiation or interrupt Baricitinib in patients with an Absolute Lymphocyte Count less than 500 cells/mm3.
Neutropenia: Avoid initiation or interrupt Baricitinib in patients with an Absolute Neutrophil Count less than 1000 cells/mm3.
Side Effects
It is not known if Baricitinib will harm an unborn baby. Because of the potential for serious adverse reactions in nursing infants, advice an Baricitinib treated woman not to breastfeed.
Pregnancy & Lactation
It is not known if Baricitinib will harm an unborn baby. Because of the potential for serious adverse reactions in nursing infants, advice an Baricitinib treated woman not to breastfeed.
Precautions & Warnings
Serious Infections: Avoid use of Baricitinib in patients with active, serious infection, including localized infections. If a serious infection develops, interrupt Baricitinib therapy until the infection is controlled. Do not give Baricitinib to patients with active tuberculosis.
Thrombosis: Use with caution in patients who may be at increased risk.
Gastrointestinal Perforations: Use with caution in patients who may be at increased risk.
Laboratory Assessment: Recommended due to potential changes in lymphocytes, neutrophils, hemoglobin, liver enzymes, and lipids.
Vaccinations: Avoid use of Baricitinib with live vaccines
Overdose Effects
In case of an overdose, it is recommended that the patient should be monitored for signs and symptoms of adverse reactions. Patients who develop adverse reactions should receive appropriate treatment.
Storage Conditions
Store below 30°C. Protect from light & moisture. Keep all medicines out of the reach of children.
Alternative brands of Baricitinib
Other brands with the same generic name, cheapest first.